NeoGenomics, Inc. (NEO)
7.995
+0.24
(+3.16%)
USD |
NASDAQ |
Apr 02, 16:00
8.00
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Market Cap : 1.038B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 2.210B |
| Amphastar Pharmaceuticals, Inc. | 937.91M |
| Krystal Biotech, Inc. | 7.684B |
| Alignment Healthcare, Inc. | 4.027B |
| Monte Rosa Therapeutics, Inc. | 1.360B |
Market Cap Related Metrics
| PS Ratio | 1.408 |
| PEG Ratio | -0.2654 |
| Price to Book Value | 1.241 |
| Price | 7.995 |
| Earnings Yield | -10.56% |
| PEGY Ratio | -0.2654 |